Who owns Sana Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SANA from SEC Form 13F filings across 202 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 202 institutions disclosed 229.6M shares of Sana Biotechnology, Inc. worth $669.1M — about 74.8% of shares outstanding; the largest disclosed holder is ARCH Venture Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
202
13F holders
$669.1M
value, 2026 filers
74.8%
of shares outstanding (229.6M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SANA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ARCH Venture Management, LLCNEW | 45.9M | $133.7M | 8.3% | 14.9% | new |
| 2 | FMR LLC | 37.3M | $108.7M | 0.0% | 12.1% | -0.4% |
| 3 | Flagship Pioneering, LLC | 25.0M | $72.9M | 3.7% | 8.1% | 0.0% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 18.8M | $54.7M | 0.5% | 6.1% | 0.0% |
| 5 | BlackRock, Inc. | 16.4M | $47.8M | 0.0% | 5.3% | -1.7% |
| 6 | CANADA PENSION PLAN INVESTMENT BOARD | 10.2M | $29.8M | 0.0% | 3.3% | 0.0% |
| 7 | STATE STREET CORP | 9.6M | $27.9M | 0.0% | 3.1% | -14.5% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 8.6M | $25.1M | 0.0% | 2.8% | +2.8% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 4.7M | $13.6M | 0.0% | 1.5% | -0.6% |
| 10 | BANK OF AMERICA CORP /DE/ | 4.6M | $13.5M | 0.0% | 1.5% | -19.4% |
| 11 | Marex Group Ltd | 4.0M | $11.6M | 0.0% | 1.3% | 0.0% |
| 12 | MORGAN STANLEY | 3.0M | $8.8M | 0.0% | 1% | +165.2% |
| 13 | Alphabet Inc. | 2.8M | $8.2M | 0.0% | 0.9% | 0.0% |
| 14 | GOLDMAN SACHS GROUP INC | 2.7M | $7.8M | 0.0% | 0.9% | +13.2% |
| 15 | MARSHALL WACE, LLP | 2.3M | $6.6M | 0.0% | 0.7% | -22.9% |
| 16 | Integral Health Asset Management, LLC | 2.0M | $5.8M | 0.4% | 0.7% | 0.0% |
| 17 | TORONTO DOMINION BANK | 2.0M | $5.8M | 0.0% | 0.6% | +0.3% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8M | $5.3M | 0.0% | 0.6% | -3.3% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.7M | $5.0M | 0.0% | 0.6% | +23.2% |
| 20 | NORTHERN TRUST CORP | 1.5M | $4.3M | 0.0% | 0.5% | -7.5% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 1.4M | $4.1M | 0.0% | 0.5% | +15.5% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 1.4M | $4.0M | 0.0% | 0.4% | +11.0% |
| 23 | Woodline Partners LP | 1.3M | $3.8M | 0.0% | 0.4% | 0.0% |
| 24 | CITADEL ADVISORS LLC | 1.2M | $3.5M | 0.0% | 0.4% | +642.2% |
| 25 | UBS Group AG | 1.1M | $3.3M | 0.0% | 0.4% | +5.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.